Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |